MedTrace Logo

Evaluation of Exufiber Ag+ and Other Gelling Fibre Dressings

NCT03249909 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2020-09-29

Study results available
· View outcomes & findings →

Summary

Investigate impact of gelling fiber dressings on handling exudate in medium to high exuding wounds

Conditions

  • Wounds and Injuries

Interventions

DEVICE

Exufiber Ag+

gelling fibre dressing with silver

DEVICE

Exufiber

gelling fibre without silver

DEVICE

Aquacel Ag Extra

gelling fibre with silver

Sponsors & Collaborators

  • Molnlycke Health Care AB

    lead INDUSTRY

Principal Investigators

  • Hadar Lev-Tov, MD, MAS · University of Miami

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-11
Primary Completion
2019-08-19
Completion
2019-08-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03249909 on ClinicalTrials.gov